Target intelligence / Profile preview

Pathogenic microbial surface epitopes

Molecular classification
Other
01

Overview

Pathogenic microbial surface epitopes are diverse molecular structures, including proteins, carbohydrates, and lipids, found on the exterior of infectious agents such as bacteria, viruses, and fungi (Janeway et al., Immunobiology, 2001). These epitopes are critical for pathogen survival and pathogenesis, often mediating host cell attachment, entry, and immune evasion (Casadevall & Pirofski, 2003). In therapeutic development, they serve as the primary targets for vaccines and monoclonal antibodies, which aim to neutralize the pathogen or mark it for destruction by the host immune system (Graham et al., 2019). For instance, monoclonal antibodies like palivizumab target the F protein epitope of Respiratory Syncytial Virus to prevent infection in high-risk infants (Beigel et al., 2019). However, the effectiveness of targeting these epitopes can be challenged by antigenic variation, where pathogens mutate their surface structures to escape immune recognition (Harvey et al., 2021). Consequently, identifying conserved epitopes is a major focus of modern reverse vaccinology and drug design (Rappuoli, 2000).

Other names
Microbial surface antigensPathogen surface epitopesSurface-exposed microbial antigensMicrobial surface components recognizing adhesive matrix molecules (MSCRAMMs)
02

Mechanism of action

Neutralization of viral or bacterial entry, opsonization for phagocytosis, and activation of the complement system to induce pathogen lysis.

03

Biological functions

Immune responseHost-pathogen interactionCell adhesionInvasionImmune evasion
04

Disease associations

Infection
05

Safety considerations

Molecular mimicry leading to autoimmunityAntigenic drift and shift leading to therapeutic escapeAntibody-dependent enhancement (ADE)Hypersensitivity reactions
06

Interacting drugs

Palivizumab

11 more in the full profile.

07

Biomarkers

Serum antibody titersAntigenemia levelsPathogen-specific T-cell responseNeutralizing antibody levels

Beyond the preview

Go deeper on Pathogenic microbial surface epitopes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic microbial surface epitopes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call